Maynard Um
-
-
-
-
-
-
-
Cytokinetics presents new MYQORZO data at ESC Heart Failure 2026
-
-
-
-
-
-
-
Cytokinetics announces nine presentations at heart failure conference
-
-
-
-
-
-
-
Leerink Partners Reiterates Outperform Rating on Cytokinetics (CYTK) following conference
-
-
-
-
-
-
-
Cytokinetics gets European approval for heart drug MYQORZO
-
-
-
-
-
-
-
Cytokinetics (CYTK) PT Raised to $84 at Needham
-
-
-
-
-
-
-
Cytokinetics receives China approval for heart drug MYQORZO
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Cytokinetics (CYTK) at Overweight Post Model Update
-
426,847 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

